This is a StreetInsider.com Premium Only Page

AVEO Oncology (AVEO) – StreetInsider.com Reports

Jan 6, 2023 05:52 AM AVEO Oncology (AVEO) Shareholders Approve Acquisition by LG Chem

Nov 8, 2022 03:46 AM Stifel Downgrades AVEO Pharmaceuticals (AVEO) to Hold

Oct 31, 2022 04:06 AM Jones Trading Downgrades AVEO Pharmaceuticals (AVEO) to Hold

Oct 19, 2022 06:39 AM UPDATE: H.C. Wainwright Downgrades AVEO Pharmaceuticals (AVEO) to Neutral

Oct 19, 2022 05:25 AM Increasing unusual call option volume: AVEO TCDA XP KBH ADT ACI

Oct 18, 2022 07:12 PM Baird Downgrades AVEO Pharmaceuticals (AVEO) to Neutral

Oct 18, 2022 07:06 AM LG Chem to Acquire AVEO Oncology (AVEO) for $15.00 Per Share in Cash

Oct 12, 2022 04:05 PM AVEO Oncology (AVEO) Granted Patent Application Covering Use of FOTIVDA

Jun 22, 2022 08:04 AM AVEO Oncology (AVEO) Enters Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ERBITUX

May 5, 2022 07:14 AM AVEO Oncology (AVEO) Misses Q1 EPS by 5c

Mar 14, 2022 01:05 PM AVEO Pharmaceuticals (AVEO) PT Lowered to $14 at Stifel

Mar 14, 2022 12:58 PM Jones Trading Starts AVEO Pharmaceuticals (AVEO) at Buy

Mar 14, 2022 07:26 AM AVEO Oncology (AVEO) Tops Q4 EPS by 8c

Feb 22, 2022 08:01 AM Actinium Pharma (ATNM) and AVEO Oncology (AVEO) Enter Research Collaboration Agreement to Develop First-in-Class Actinium-225 ErbB3 Targeting Radiotherapy for Solid Tumors

Feb 14, 2022 05:01 PM AVEO Oncology (AVEO) to Present Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA

Jan 4, 2022 04:22 PM UPDATE: AVEO Pharmaceuticals (AVEO) PT Lowered to $15 at Stifel

Jan 4, 2022 08:05 AM AVEO Oncology (AVEO) Highlights Recent Progress and 2022 Outlook

Dec 1, 2021 07:01 AM AVEO Oncology (AVEO) Announces Appointment of Jeb Ledell as Chief Operating Officer

Nov 9, 2021 07:53 AM AVEO Pharmaceuticals (AVEO) PT Lowered to $18 at Stifel

Nov 8, 2021 04:29 PM AVEO Oncology (AVEO) Tops Q3 EPS by 6c; Reports Cash and Cash Equivalents of $94.0M

Sep 20, 2021 07:05 AM AVEO Oncology's (AVEO) Ficlatuzumab Granted Fast Track Designation by the FDA

Aug 5, 2021 05:07 PM AVEO Oncology (AVEO) Tops Q2 EPS by 5c

Jul 12, 2021 06:36 AM AVEO Pharmaceuticals (AVEO) PT Lowered to $19 at H.C. Wainwright

May 19, 2021 05:05 PM AVEO Oncology (AVEO) Announces Presentation of Long-Term Efficacy Follow Up, Additional Tolerability Data from the Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Relapsed or Refractory Renal Cell Ca

May 11, 2021 07:07 AM AVEO Pharmaceuticals (AVEO) PT Lowered to $19 at Stifel

May 10, 2021 04:35 PM AVEO Oncology (AVEO) Misses Q1 EPS by 26c

Apr 16, 2021 07:02 AM AVEO Oncology (AVEO) Adds Kevin Cullen, M.D. to Board

Mar 29, 2021 07:05 AM AVEO Oncology (AVEO) Announces Addition of FOTIVDA into National Comprehensive Cancer Network Clinical Practice Guidelines

Mar 24, 2021 06:04 AM AVEO Oncology (AVEO) Prices 6M Share Common Offering at $8/Sh

Mar 23, 2021 09:28 AM Pre-Open Movers 03/23: (ORMP) (TKAT) (BLFS) Higher; (FREQ) (ANIX) (IONX) Lower (more...)

Mar 22, 2021 05:44 PM After-Hours Stock Movers 03/22: (BLFS) (CHMA) (PTGX) Higher; (IONS) (RAVN) (QS) Lower (more...)

Mar 22, 2021 04:02 PM AVEO Oncology (AVEO) Announces 5M Share Proposed Public Offering of Common Stock

Mar 22, 2021 07:03 AM AVEO Oncology (AVEO) Announces U.S. Commercial Availability of FOTIVDA for Treatment of Adult Patients With R/R Advanced RCC Ahead of Previous Guidance

Mar 15, 2021 07:17 AM AVEO Oncology (AVEO) to Regain Ex-North American Rights to AV-203

Mar 12, 2021 07:02 AM AVEO Oncology (AVEO) Announces Collaboration with Bristol Myers Squibb (BMY) to Evaluate FOTIVDA in Combination with OPDIVO in Pivotal Phase 3 TiNivo-2 Trial in IO Relapsed Renal Cell Carcinoma

Mar 11, 2021 09:28 AM Pre-Open Stock Movers 03/11: (SIEB) (VIR) (RBLX) Higher; (ALTO) (SUMO) (ORCL) Lower (more...)

Mar 11, 2021 08:47 AM AVEO Pharmaceuticals (AVEO) PT Raised to $22 at Stifel

Mar 11, 2021 06:32 AM AVEO Pharmaceuticals (AVEO) PT Raised to $18 at SVB Leerink

Mar 11, 2021 02:33 AM Increasing option volume: AVEO TRTN GTT IWN SLM EXPR HSBC

Mar 10, 2021 05:39 PM After-Hours Stock Movers 03/10: (SIEB) (AVEO) (AMC) Higher; (ALTO) (CLDR) (KDMN) Lower (more...)

Mar 10, 2021 03:25 PM AVEO Oncology (AVEO) Confirms U.S. FDA Approval of FOTIVDA (tivozanib) for Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma

Mar 10, 2021 03:08 PM AVEO Oncology (AVEO) Halted Again on LUDP, Up 71%

Mar 10, 2021 02:52 PM AVEO Oncology (AVEO) Halted on LUDP

Mar 10, 2021 02:51 PM AVEO Oncology (AVEO) Receives FDA Approval of TIVOZANIB

Jan 15, 2021 08:01 AM AVEO Oncology (AVEO) Reports Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA) in Combination with IMFINZI (durvalumab)

Jan 7, 2021 07:20 AM AVEO Oncology (AVEO) Highlights Recent Progress and 2021 Outlook

Nov 9, 2020 04:36 AM Stifel Starts AVEO Pharmaceuticals (AVEO) at Buy

Sep 16, 2020 09:27 AM Pre-Open Stock Movers 09/16: (KODK) (AXGN) (AMCX) Higher; (ADT) (NKLA) (NNOX) Lower (more...)

Sep 15, 2020 05:26 PM After-Hours Movers 09/15: (AXGN) (AMCX) (FDX) Higher; (NKLA) (SYNH) Lower (more...)

Sep 15, 2020 04:10 PM AVEO Oncology (AVEO) Announces European Urology Publication of Final Overall Survival Data from Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma